David Dum

1.8k total citations
16 papers, 115 citations indexed

About

David Dum is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Dum has authored 16 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Dum's work include Genetic factors in colorectal cancer (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). David Dum is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). David Dum collaborates with scholars based in Germany and United States. David Dum's co-authors include Franziska Büscheck, Guido Sauter, Ronald Simon, Claudia Hube‐Magg, Eike Burandt, Doris Höflmayer, Stefan Steurer, Till S. Clauditz, Georgia Makrypidi‐Fraune and Martina Kluth and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Cancer.

In The Last Decade

David Dum

14 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dum Germany 6 55 42 31 26 24 16 115
Thais Maloberti Italy 6 62 1.1× 31 0.7× 54 1.7× 29 1.1× 32 1.3× 40 164
Ming-Mo Hou Taiwan 7 52 0.9× 54 1.3× 45 1.5× 19 0.7× 17 0.7× 9 129
Mariaelena Casagrande Italy 8 91 1.7× 45 1.1× 15 0.5× 22 0.8× 37 1.5× 21 123
Erik Asmus United States 6 100 1.8× 41 1.0× 39 1.3× 16 0.6× 17 0.7× 9 179
Jennifer Borowsky Australia 8 108 2.0× 41 1.0× 36 1.2× 69 2.7× 27 1.1× 10 174
Abirami Sivapiragasam United States 8 107 1.9× 40 1.0× 37 1.2× 23 0.9× 41 1.7× 33 178
Joseph Hreiki United States 5 74 1.3× 21 0.5× 55 1.8× 21 0.8× 44 1.8× 6 159
Nieves Martínez Lago Spain 8 121 2.2× 51 1.2× 40 1.3× 29 1.1× 12 0.5× 44 165
Qingxia Fan China 7 112 2.0× 49 1.2× 20 0.6× 28 1.1× 37 1.5× 17 156
Petra Jankowska United Kingdom 4 34 0.6× 24 0.6× 35 1.1× 12 0.5× 31 1.3× 6 141

Countries citing papers authored by David Dum

Since Specialization
Citations

This map shows the geographic impact of David Dum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dum more than expected).

Fields of papers citing papers by David Dum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dum. The network helps show where David Dum may publish in the future.

Co-authorship network of co-authors of David Dum

This figure shows the co-authorship network connecting the top 25 collaborators of David Dum. A scholar is included among the top collaborators of David Dum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dum. David Dum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Amsberg, Gunhild von, David Dum, Derya Tilki, et al.. (2025). Targeting TROP2 in aggressive variant and neuroendocrine prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 171–171.
2.
Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations
3.
Lennartz, Maximilian, Niclas C. Blessin, Claudia Hube‐Magg, et al.. (2023). TRPS1 is a highly sensitive marker for breast cancer: A tissue microarray study evaluating more than 19,000 tumors from 152 different tumor entities. American Journal of Clinical Pathology. 160(Supplement_1). S12–S13. 2 indexed citations
4.
Dum, David, Stefan Steurer, Ronald Simon, et al.. (2021). Mismatch repair deficiency occurs very rarely in seminomas. Translational Andrology and Urology. 10(3). 1048–1055. 5 indexed citations
5.
Dum, David & Till Krech. (2021). SATB2 expression in human tumors: A tissue microarray study on more than 15,000 tumors. American Journal of Clinical Pathology. 156(Supplement_1). S109–S109. 3 indexed citations
6.
Uhlig, Ria, Sören Weidemann, Doris Hoeflmayer, et al.. (2021). Carboxypeptidase A1 (CPA1) immunohistochemistry is highly sensitive and specific for acinar cell carcinoma (ACC) of the pancreas. Pathology. 53. S43–S43. 2 indexed citations
7.
Dum, David, Niclas C. Blessin, Tim Mandelkow, et al.. (2021). Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence. American Journal of Clinical Pathology. 156(Supplement_1). S137–S138. 1 indexed citations
8.
Weidemann, Sören, Natalia Gorbokon, Doris Höflmayer, et al.. (2021). Abstract 2833: Mesothelin expression in human tumor types: a tissue microarray study on more than 13,000 tumor samples. Cancer Research. 81(13_Supplement). 2833–2833. 1 indexed citations
9.
Fraune, Christoph, Ronald Simon, Claudia Hube‐Magg, et al.. (2020). MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass. Urologic Oncology Seminars and Original Investigations. 38(5). 488–495. 19 indexed citations
10.
Fraune, Christoph, Ronald Simon, Claudia Hube‐Magg, et al.. (2020). Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas. Endocrine Pathology. 31(2). 182–189. 14 indexed citations
11.
Kluth, Martina, Claudia Hube‐Magg, Georgia Makrypidi‐Fraune, et al.. (2020). Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG‐negative prostate cancer. The Prostate. 80(13). 1097–1107. 18 indexed citations
12.
Kluth, Martina, Claudia Hube‐Magg, Georgia Makrypidi‐Fraune, et al.. (2020). High B7‐H3 expression is linked to increased risk of prostate cancer progression. Pathology International. 70(10). 733–742. 19 indexed citations
13.
Möller, Katharina, Martina Kluth, Lia Burkhardt, et al.. (2020). Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer. International Journal of Cancer. 148(3). 748–758. 4 indexed citations
14.
Fraune, Christoph, Andreas M. Luebke, Stefan Steurer, et al.. (2020). Upregulation of PTTG1 is associated with poor prognosis in prostate cancer. Pathology International. 70(7). 441–451. 10 indexed citations
15.
Fraune, Christoph, Ronald Simon, Doris Höflmayer, et al.. (2019). High homogeneity of mismatch repair deficiency in advanced prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(5). 745–752. 14 indexed citations
16.
Dum, David, et al.. (2019). Chorioangiom der Plazenta – eine seltene Ursache fetaler High-Output-Herzinsuffizienz. Zeitschrift für Geburtshilfe und Neonatologie. 224(2). 103–106. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thais Maloberti Breakdown of academic impact, for papers by Ming-Mo Hou Breakdown of academic impact, for papers by Mariaelena Casagrande Breakdown of academic impact, for papers by Erik Asmus Breakdown of academic impact, for papers by Jennifer Borowsky Breakdown of academic impact, for papers by Abirami Sivapiragasam Breakdown of academic impact, for papers by Joseph Hreiki Breakdown of academic impact, for papers by Nieves Martínez Lago Breakdown of academic impact, for papers by Qingxia Fan Breakdown of academic impact, for papers by Petra Jankowska
Rankless by CCL
2026